Biohub, US science agencies, Google and Meta are combining measurement technology, computing and biological datasets to train predictive cell models—but a reliable virtual cell remains a target, not a finished product.
The laureates showed how tiny molecular imbalances can be amplified until a reaction strongly favors one mirror-image form, advancing asymmetric synthesis and the chemistry behind medicines.
The IceCube architect is honored for opening a new window on the high-energy universe, using more than 5,000 sensors buried deep beneath the South Pole.
Karl Deisseroth, Peter Hegemann and Georg Nagel will share the prize for discoveries that turned microbial light sensors into a precise way to switch selected nerve cells on and off.
The global partnership will fund later-stage testing of lixudebart across rare kidney and liver diseases. Its anti-fibrotic promise remains unproven in a pivotal trial.
The Kyoto Vision backs new research-funding models, wider access to AI and stronger scientific integrity. It is a political signal rather than a funded or binding implementation plan.
A Delaware judge ruled that the federal government’s license to university inventions does not automatically protect a private supplier. Moderna’s separate government-contract defense—and the underlying infringement claims—remain unresolved.
A compact deep-learning model distinguished young from aged mouse blood stem cells by reading subtle patterns in DAPI-stained nuclei. Its most immediate value is as a research-screening tool—not a clinical age test or proof of cellular rejuvenation.
Researchers carbonized a laboratory-made papyrus scroll, detected lead-spiked writing with handheld X-ray fluorescence and reconstructed readable text from CT data. The proof of concept could help identify which surviving Herculaneum scrolls are best suited for virtual unrolling.